News About: Pharm. Industry
Dong-A considers revising articles of incorporation
Dong-A Pharmaceutical Co. is considering revising the Articles of Incorporation to protect its managerial control ahead of its shareholders meeting on March 14.
On March 6, the company filed a public notice, announ...
ReNu MultiPlus solution proven to be effective against germs
Bausch & Lomb says it has received from the Korea Food and Drug Administration its ReNu MultiPlus Multi-Purpose solution to effectively kills germs, such as acanthamoeba, in just 4 hours so it helps keep the soft con...
Icure develops donepezil patch
Icure, a local drug delivery system developer, said on March 6 it has succeeded in developing donepezil patch whose efficacy lasts 7 days, following Novartis's Excelon.
A new treatment is in development for Alzheim...
KPMA reaffirms transparent trade
The Korea Pharmaceutical Manufacturer Association says it will stamp out some common types of unfair practices, such as price fixing and illicit inducement of customers through by revising the current self-purificatio...
Yuhan's Revanex has fared well in anti-ulcerant market
With the renormalized distribution last week, Yuhan's novel proton inhibitor Revanex (revaprazan) is expanding its share of the domestic anti-ulcerant market.
Revanex' sales have exceeded the 10 billion won mark in...
Controversy erupts over Bayer's new payment policy
The Korean Association of Pharmaceutical Wholesaler plans to discuss the new Bayer sales policy as an agenda at March 12 meeting, amid various reactions from ethical and OTC wholesalers.
According to Bayer Korea's ...
Pfizer Korea, Korean drugmakers to face off in Lipitor war
Now that Pfizer's Lipitor market thought to be still increasing, several Korean pharmaceutical firms are now focusing on the market with their generic products.
The run-ups include Hanmi Pharm, Yuhan Corporation, D...
Drugmakers, wholesalers to re-establish anti-dumping order
Major pharmaceutical firms has agreed to make any dumping acts at hospital biddings, as there is general consensus that such dumping acts may affect related pharmaceutical firms and hospitals as well as drug wholesale...
Multinationals seek diverse distribution networks
Stimulated by growing friction between Zuellig Pharma Korea and its associated wholesalers last year, some foreign-invested pharmaceutical firms plan to make direct transactions with Zuellig's associate wholesalers as...
Park named marketing manager of Janssen TaiwanPark Myung-chul, deputy manager of Janssen Korea, has been named to the marketing manger at Janssen Taiwan, Janssen Korea said recently.
He will be involved in all of the mar...
|
